Outcomes of Medicare Beneficiaries With Heart Failure and Atrial Fibrillation

JACC: Heart Failure

Volumn 2, Issue 1, 2014, Pages 41-48

  Khazanie, Prateeti ^a,b   Liang, Li ^a   Qualls, Laura G ^a   Curtis, Lesley H ^a,b   Fonarow, Gregg C ^c   Hammill, Bradley G ^a   Hammill, Stephen C ^d   Heidenreich, Paul A ^e   Masoudi, Frederick A ^f   Hernandez, Adrian F ^a,b   Piccini, Jonathan P ^a,b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MAYO CLINIC   (United States)

^e VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^f UNIVERSITY OF COLORADO   (United States)

Author keywords

Atrial fibrillation; Heart failure; Medicare; Mortality; Outcome assessment (health care); Patient readmission

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; NEW ONSET ATRIAL FIBRILLATION; OUTCOME ASSESSMENT; PRE EXISTING ATRIAL FIBRILLATION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; VERY ELDERLY; ATRIAL FIBRILLATION; COMPLICATION; EPIDEMIOLOGY; HOSPITALIZATION; STATISTICS AND NUMERICAL DATA; UNITED STATES; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; EPIDEMIOLOGIC METHODS; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; PROGNOSIS; UNITED STATES;

EID: 84892981805     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2013.11.002     Document Type: Article

References (30)

1. Mountantonakis S.E., Grau-Sepulveda M.V., Bhatt D.L., Hernandez A.F., Peterson E.D., Fonarow G.C. Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of Get With The Guidelines-Heart Failure. Circ Heart Fail 2012, 5:191-201.
2. Ahmed A., Thornton P., Perry G.J., Allman R.M., DeLong J.F. Impact of atrial fibrillation on mortality and readmission in older adults hospitalized with heart failure. Eur J Heart Fail 2004, 6:421-426.
3. Dries D.L., Exner D.V., Gersh B.J., Domanski M.J., Waclawiw M.A., Stevenson L.W. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998, 32:695-703.
4. Olsson L.G., Swedberg K., Ducharme A., et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol 2006, 47:1997-2004.
5. Rivero-Ayerza M., Scholte Op Reimer W., Lenzen M., et al. New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey. Eur Heart J 2008, 29:1618-1624.
6. Swedberg K., Olsson L.G., Charlesworth A., et al. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. Eur Heart J 2005, 26:1303-1308.
7. Carson P.E., Johnson G.R., Dunkman W.B., Fletcher R.D., Farrell L., Cohn J.N. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation 1993, 87:VI102-VI110.
8. Hong Y., LaBresh K.A. Overview of the American Heart Association "Get with the Guidelines" programs: coronary heart disease, stroke, and heart failure. Crit Pathw Cardiol 2006, 5:179-186.
9. Fonarow G.C., Abraham W.T., Albert N.M., et al. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. Am Heart J 2004, 148:43-51.
10. Hammill B.G., Hernandez A.F., Peterson E.D., Fonarow G.C., Schulman K.A., Curtis L.H. Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J 2009, 157:995-1000.
11. Jensen P.N., Johnson K., Floyd J., Heckbert S.R., Carnahan R., Dublin S. A systematic review of validated methods for identifying atrial fibrillation using administrative data. Pharmacoepidemiol Drug Saf 2012, 21(Suppl 1):141-147.
12. Birman-Deych E., Waterman A.D., Yan Y., Nilasena D.S., Radford M.J., Gage B.F. Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care 2005, 43:480-485.
13. Roumie C.L., Mitchel E., Gideon P.S., Varas-Lorenzo C., Castellsague J., Griffin M.R. Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data. Pharmacoepidemiol Drug Saf 2008, 17:20-26.
14. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
15. Keenan P.S., Normand S.L., Lin Z., et al. An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes 2008, 1:29-37.
16. Krumholz H.M., Wang Y., Mattera J.A., et al. An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure. Circulation 2006, 113:1693-1701.
17. Kalbfleisch J.D., Prentice R.L. The Statistical Analysis of Failure Time Data 2002, John Wiley & Sons, Hoboken, NJ. 2nd ed.
18. Gray R.J. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988, 16:1141-1154.
19. Harrell F.E. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis 2010, Springer-Verlag New York, Inc., New York, NY.
20. Nieuwlaat R., Capucci A., Camm A.J., et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2005, 26:2422-2434.
21. Nieuwlaat R., Prins M.H., Le Heuzey J.Y., et al. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur Heart J 2008, 29:1181-1189.
22. Patel M.R., Mahaffey K.W., Garg J., et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011, 365:883-891.
23. Fuster V., Rydén L.E., Cannom D.S., et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2011, 57:e100-e198.
24. Badheka A.O., Rathod A., Kizilbash M.A., et al. Comparison of mortality and morbidity in patients with atrial fibrillation and heart failure with preserved versus decreased left ventricular ejection fraction. Am J Cardiol 2011, 108:1283-1288.
25. van Diepen S., Hellkamp A.S., Patel M.R., et al. Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: insights from ROCKET AF. Circ Heart Fail 2013, 6:740-747.
26. McMurray J.J., Ezekowitz J.A., Lewis B.S., et al. Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial. Circ Heart Fail 2013, 6:451-460.
27. Heidenreich P.A., Fonarow G.C. Are registry hospitals differentα A comparison of patients admitted to hospitals of a commercial heart failure registry with those from national and community cohorts. Am Heart J 2006, 152:935-939.
28. Curtis L., Hernandez A., Greiner M., Fonarow G., Schulman K. Validity of a national heart failure quality of care registry: comparison of Medicare patients in OPTIMIZE-HF versus non-OPTIMIZE-HF hospitals. Circulation 2007, 115:e595.
29. Quach S., Blais C., Quan H. Administrative data have high variation in validity for recording heart failure. Can J Cardiol 2010, 26:306-312.
30. Kokotailo R.A., Hill M.D. Coding of stroke and stroke risk factors using International Classification of Diseases, revisions 9 and 10. Stroke 2005, 36:1776-1781.